Nonsense? I want to know why you think institutional ownership will increase the stock price? Last I checked, strong financial results. We can all agree that the market potential for NIPT and LB are huge, but that fact has not lead to higher share prices for SQNM--- you gotta ask yourself why?
Labguy64 has a good point--- the 540 holy grail was a total joke.... There are competitors who have the same or more insurance contracts in place than SQNM and they were late to the party.
LB sounds promising, but only if Flately where at the helm.
They had 5 analyst ask questions on the call--- what did SQNM have, 2?
They are going with the direct sales model and going after market share in avg risk even though they are not being reimbursed on all of it. Reminds me of what SQNM did when they first launched the high risk test.
There were 2 analysts on the call--- doesn't that tell us all we need to know? This stock sucks so damn bad they can't even get anyone to show up and ask questions. Why should they, when management has a history of dodging questions.
No kidding- 2020 is where it's at. What was the number they arbitrarily threw out there with absolutely no logical explanation on how they get there?
Max- probably not a bad idea on the tax loss strategy. All our competitors are moving into cancer diagnostics as well. Big market, but with reimbursement issues and lack of clarity from FDA on LDT's it's hard to say if and when $$$ will start pouring in.
Companies don't share the details- they will get sued if they say something negative about WW. He was a turd and they flushed him down the toilet.
That's not the only area we have been lacking-- Sequenom has been lacking a PR department, competent management, revenues, profitability.... Should I continue?